Rasmus Mortensen

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 19

Top Venues

NPJ vaccines

Communications biology

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

Statens Serum Institut

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Statens Serum Institut

Denmark

Head of TB Vaccine Research :: Department of Infectious Disease Immunology

Publications

Rasmus Mortensen, Helena Strand Clemmensen, Joshua S Woodworth, Marie Louise Therkelsen, Tehmina Mustafa, Kristian Tonby, Synne Jenum, Else Marie Agger, Anne Ma Dyrhol-Riise, Peter Andersen
Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice. Communications biology 7 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Rasmus Mortensen, Helena Strand Clemmensen, Joshua S Woodworth, Marie Louise Therkelsen, Tehmina Mustafa, Kristian Tonby, Synne Jenum, Else Marie Agger, Anne Ma Dyrhol-Riise, Peter Andersen
Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice. Communications biology 7 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Karin Dijkman, Thomas Lindenstrøm, Ida Rosenkrands, Rikke Søe, Joshua S Woodworth, Cecilia S Lindestam Arlehamn, Rasmus Mortensen
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Karin Dijkman, Thomas Lindenstrøm, Ida Rosenkrands, Rikke Søe, Joshua S Woodworth, Cecilia S Lindestam Arlehamn, Rasmus Mortensen
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. NPJ vaccines 8 (1) (2023)
Karin Dijkman, Thomas Lindenstrøm, Ida Rosenkrands, Rikke Søe, Joshua S Woodworth, Cecilia S Lindestam Arlehamn, Rasmus Mortensen
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. NPJ vaccines 8 (1) (2023)
Helena Strand Clemmensen, Jean-Yves Dube, Fiona McIntosh, Ida Rosenkrands, Gregers Jungersen, Claus Aagaard, Peter Andersen, Marcel A Behr, Rasmus Mortensen
In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection. mBio 12 (2) (2021)
Joshua S Woodworth, Helena Strand Clemmensen, Hannah Battey, Karin Dijkman, Thomas Lindenstrøm, Raquel Salvador Laureano, Randy Taplitz, Jeffrey Morgan, Claus Aagaard, Ida Rosenkrands, Cecilia S Lindestam Arlehamn, Peter Andersen, Rasmus Mortensen
A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin. Nature communications 12 (1) (2021)
Synne Jenum, Kristian Tonby, Corina Silvia Rueegg, Morten Rühwald, Max P Kristiansen, Peter Bang, Inge Christoffer Olsen, Kjersti Sellæg, Kjerstin Røstad, Tehmina Mustafa, Kjetil Taskén, Dag Kvale, Rasmus Mortensen, Anne Margarita Dyrhol-Riise
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nature communications 12 (1) (2021)
Claus Aagaard, Niels Peter Hell Knudsen, Iben Sohn, Angelo A Izzo, Hongmin Kim, Emma Holsey Kristiansen, Thomas Lindenstrøm, Else Marie Agger, Michael Rasmussen, Sung Jae Shin, Ida Rosenkrands, Peter Andersen, Rasmus Mortensen
Immunization with Mycobacterium tuberculosis-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guérin Vaccination and Improves Protection in Mice. Journal of immunology (Baltimore, Md. : 1950) 205 (8) (2020)
Rasmus Mortensen, Helena Strand Clemmensen, Joshua S Woodworth, Marie Louise Therkelsen, Tehmina Mustafa, Kristian Tonby, Synne Jenum, Else Marie Agger, Anne Ma Dyrhol-Riise, Peter Andersen
Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice. Communications biology 2 (2019)
Manisha Pandey, Rasmus Mortensen, Ainslie Calcutt, Jessica Powell, Michael R Batzloff, Jes Dietrich, Michael F Good
Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci. Journal of immunology (Baltimore, Md. : 1950) 196 (8) (2016)

Rasmus Mortensen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rasmus Mortensen